1. Home
  2. ELOG vs BIVI Comparison

ELOG vs BIVI Comparison

Compare ELOG & BIVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ELOG

Eastern International Ltd. Ordinary Shares

HOLD

Current Price

$0.82

Market Cap

12.4M

Sector

Industrials

ML Signal

HOLD

Logo BioVie Inc.

BIVI

BioVie Inc.

HOLD

Current Price

$1.37

Market Cap

11.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ELOG
BIVI
Founded
2006
2013
Country
China
United States
Employees
N/A
N/A
Industry
Integrated Freight & Logistics
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.4M
11.1M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
ELOG
BIVI
Price
$0.82
$1.37
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
7.9K
89.1K
Earning Date
07-17-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$6.84
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.80
$0.88
52 Week High
$3.07
$9.09

Technical Indicators

Market Signals
Indicator
ELOG
BIVI
Relative Strength Index (RSI) 34.69 39.98
Support Level N/A $1.16
Resistance Level $1.19 $1.52
Average True Range (ATR) 0.04 0.14
MACD -0.01 -0.03
Stochastic Oscillator 4.57 4.65

Price Performance

Historical Comparison
ELOG
BIVI

About ELOG Eastern International Ltd. Ordinary Shares

Eastern International Ltd is a holding company. The company operates through its subsidiary engaged in domestic and cross-border professional logistic services including project logistics and general logistics for company clients. Its project logistic services include Construction project logistics and special cargo logistics for large or precision equipment and General logistic services refer to the transportation, warehousing, loading and unloading, and distribution of ordinary products. Its segments are Transportation services and Warehouse subleasing services. The group generates the majority of its revenue from Transportation services.

About BIVI BioVie Inc.

BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.

Share on Social Networks: